Pharmaceutical Technologist - September 2007 - (Page 27)

// Beauchamp MHRA assesses the labelling provided with mutual recognition and national licence applications. The guidelines include design recommendations, such as the use of large fonts and colours in labelling to aid recognition, as well as considering the use of white space to ensure the labels are easy to read, particularly by elderly patients. These regulations have been introduced in an effort to increase consistency in the labelling of pharmaceuticals, making packaging more patient-friendly. However, to achieve these desired results, manufacturers need to ensure they have the technology in place to produce the quality of labelling required. Printer problems Traditionally, label printers, especially the more common off-line or standalone devices, have been unreliable, bulky and inconvenient to install, and have required constant adjustments of print media by operators. Because the equipment is often being poorly designed, the media can regularly become tangled or jammed with the effect of a large mass of label ‘spaghetti’ filling the printer. The time taken to resolve these incidents and the inconvenience New guidelines include design recommendations, such as the use of large fonts and colours in labelling to aid recognition, and the use of white space to make labels easy to read. Outsourcing Validation – Taking the next step The majority of pharmaceutical companies outsource validation to some degree already. The next logical step would be to establish a partnership with a validation specialist organisation. We’d like to invite you to partner with ABB. Our team understands the needs of the Life Sciences industry, and you can draw on more than one-hundred years of experience with regulated industry. As a leading group of validation and regulatory compliance specialists we cover all validation disciplines and levels. Developing a partnership with a single partner delivers the following benefits: De-bottlenecking validation Access to pre-qualified work force familiar with your company policies and procedures Predictable validation costs Consider ABB as your representative in the regulatory arena and as validation partner for establishing a partnership approach to regulatory compliance. Do you have the time and resources to immerse yourself in regulatory developments? Would you rather focus on speeding your products to market? Are your regulatory compliance staff diverted from governance to delivery? We’re just a phone call away. Phone +44 1642 372077 www.abb.com/lifesciences www.ptemagazine.com 27 http://www.abb.com/lifesciences http://www.abb.com/lifesciences http://www.ptemagazine.com

Table of Contents Feed for the Digital Edition of Pharmaceutical Technologist - September 2007

Contents Editor’s Comment News Morpheus Market Watch CPhI Worldwide 2007 Compliant Pharmaceutical Labelling Q&A

Pharmaceutical Technologist - September 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.